Every time the NHS comes under pressure in the UK, the voices for a move to a co-payment system supported by private medical insurance (PMI) come to the fore.
The recent AMII conference was no exception. While there are undoubted merits to such systems (indeed, they are much more common than our NHS model), it is usually assumed that the result would simply be a free market for PMI insurers with a much bigger business base. In fact, where co-payment systems are in place, this is very rarely the case. Rather, with “state partnership” come restrictions. Ultimately, the restrictions can become so onerous, as in France, that the system is more akin to a bank collecting money than insurance as we know it. We do not have far to look to see how...
To continue reading this article...
Join Professional Adviser for free
- Unlimited access to real-time news, industry insights and market intelligence
- Stay ahead of the curve with spotlights on emerging trends and technologies
- Receive breaking news stories straight to your inbox in the daily newsletters
- Make smart business decisions with the latest developments in regulation, investing retirement and protection
- Members-only access to the editor’s weekly Friday commentary
- Be the first to hear about our events and awards programmes